Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MIR503HG
   Synonyms MIR503HG, H19X, MIR503HG2, MGC16121, H19X
   Region GRCh38_X:134543337-134546632    Sequence
   Ensembl ENSG00000223749
   RefSeq NR_024607
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name anaplastic large-cell lymphoma
   ICD-0-3  M9714/3
   Methods qPCR etc.
   Sample cell lines (SR-786, KARPAS, MAC-1 and FePD)
   Expression Pattern up-regulated
   Function Description

MIR503HG (miR-503 host gene) was highly expressed in ALK-negative cell lines and was significantly upregulated in tumors in mice formed from ALK-negative ALCL cell lines.Depletion of MIR503HG suppressed tumor cell proliferation in vivo and in vitro;conversely, its overexpression enhanced tumor cell growth. MIR503HG-induced proliferation was mediated by the induction of microRNA-503 (miR-503) and suppression of Smurf2, resulting in stabilization of the tumor growth factor-B receptor (TGFBR) and enhanced tumor cell growth. Collectively, these findings support a potential role for MIR503HG in cancer cell proliferation through the miR-503/Smurf2/TGFBR axis and indicate that MIR503HG is a potential marker in ALK-negative ALCL.

   Pubmed ID 29758012
   Year 2018
   Title The Long Non-Coding RNA MIR503HG Enhances Proliferation of Human ALK-Negative Anaplastic Large-Cell Lymphoma.
   External Links
   Links for  MIR503HG GenBank       HGNC       lncrnadb       Noncode
   Links for  anaplastic large-cell lymphoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.